YCM
CDIO icon

Yakira Capital Management’s Cardio Diagnostics CDIO Stock Holding History

Yakira Capital Management’s Portfolio CDIO Stock Details CDIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-692
Closed -$22K – 381
2022
Q4 		$22K Sell
692
-5,975
-90% -$645K ﹤0.01% 231
2022
Q3 		$2.01M Hold
6,667
– – 0.29% 122
2022
Q2 		$1.99M Buy
+6,667
New +$1.98M 0.31% 120

Other funds holding CDIO

LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $265M AUM 30.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Yakira Capital Management's CDIO Position: Q1 2023 in Review

Yakira Capital Management sold out of Cardio Diagnostics (CDIO) in Q1 2023, closing a stake of 692 shares — an estimated $22K sold.

Yakira Capital Management first reported a position in CDIO in Q2 2022 and held it in 3 quarters. The position peaked at $2.01M in Q3 2022. 11 funds tracked by Wall St. Rank hold CDIO as of Q1 2023.

  • Yakira Capital Management reported no remaining Cardio Diagnostics position as of Q1 2023 after selling out during the quarter.
  • Yakira Capital Management sold 692 Cardio Diagnostics shares in Q1 2023, an estimated $22K.
  • Yakira Capital Management first reported a position in Cardio Diagnostics in Q2 2022 and held it in 3 quarters.
  • Yakira Capital Management's Cardio Diagnostics position peaked at $2.01M in Q3 2022.
  • 11 funds tracked by Wall St. Rank held Cardio Diagnostics as of Q1 2023.

Based on Yakira Capital Management's 13F filing for Q1 2023, filed 12 May 2023.